Comparative in vitro study of the cytotoxicity of gelatine and alginate to human umbilical cord mesenchymal stem cells
Downloads
Background: Mesenchymalstem cells (MSCs) and scaffold combination constitute a promising approach currently adopted for tissue engineering. Umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are easily obtained and non-invasive. Gelatine and alginate constitute a biocompatible natural polymer scaffold. At present, a cytotoxicity comparison of gelatine and alginate to hUC-MSCs is not widely conducted Purpose: This study aimed to compare the cytotoxicity of gelatine and alginate in hUC-MSCs in vitro. Methods: Isolation and culture were performed on hUC-MSCs derived from healthy full-term neonates. Flow Cytometry CD90, CD105 and CD73 phenotype characterization was performed in passage 4. 3-(4,5-dimethythiazol- 2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetric assay was performed to measure the cytotoxicity. The three sample groups were: (T1) hUC-MSCs with α-MEM (alpha-minimum essential medium) solution as control; (T2) hUC-MSCs with gelatine; (T3) hUC-MSCs with alginate Results: Flow cytometry of hUC-MSCs displayed positive CD90, CD105 and CD73 surface markers. Gelatine and alginate had no effect on the viability of hUC-MSCs and no statistically significant difference (p>0.05) of cytotoxicity between gelatine and alginate to hUC-MSCs. Conclusion: Gelatine and alginate proved to be non-toxic to hUC-MSCs in vitro.
Downloads
Jimi E, Hirata S, Osawa K, Terashita M, Kitamura C, Fukushima H. The current and future therapies of bone regeneration to repair bone defects. Int J Dent. 2012; 2012: 1–7.
Wang M, Yuan Q, Xie L. Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem Cells Int. 2018; 2018: 1–12.
El Omar R, Beroud J, Stoltz J-F, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev. 2014; 20(5): 523–44.
Shen C, Yang C, Xu S, Zhao H. Comparison of osteogenic differentiation capacity in mesenchymal stem cells derived from human amniotic membrane (AM), umbilical cord (UC), chorionic membrane (CM), and decidua (DC). Cell Biosci. 2019; 9: 17.
Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010; 3(4): 248–69.
Patel H, Bonde M, Srinivasan G. Biodegradable polymer scaffold for tissue engineering. Trends Biomater Artif Organs. 2011; 25: 20–9.
Saber SEM. Tissue engineering in endodontics. J Oral Sci. 2009; 51(4): 495–507.
Tayebi L, Moharamzadeh K. Biomaterials for oral and dental tissue engineering. Sheffield: Woodhead Publishing; 2017. p. 29–30.
Chan G, Mooney DJ. New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol. 2008; 26(7): 382–92.
Chang B, Ahuja N, Ma C, Liu X. Injectable scaffolds: preparation and application in dental and craniofacial regeneration. Mater Sci Eng R Reports. 2017; 111: 1–26.
Park H, Kang S-W, Kim B-S, Mooney DJ, Lee KY. Shear-reversibly crosslinked alginate hydrogels for tissue engineering. Macromol Biosci. 2009; 9(9): 895–901.
Liao H-T, Shalumon KT, Chang K-H, Sheu C, Chen J-P. Investigation of synergistic effects of inductive and conductive factors in gelatin-based cryogels for bone tissue engineering. J Mater Chem B. 2016; 4(10): 1827–41.
Hendrijantini N, Kresnoadi U, Salim S, Agustono B, Retnowati E, Syahrial I, Mulawardhana P, Wardhana MP, Pramono C, Rantam FA. Study biocompatibility and osteogenic differentiation potential of human umbilical cord mesenchymal stem cells (hUCMSCs) with gelatin solvent. J Biomed Sci Eng. 2015; 8(7): 420–8.
Wang Z, Goh J, Das De S, Ge Z, Ouyang H, Chong JSW, Low SL, Lee EH. Efficacy of bone marrow – derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng. 2006; 12(7): 1753–61.
Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int. 2016; 2016: 1–17.
Machado C de V, Telles PD da S, Nascimento ILO. Immunological characteristics of mesenchymal stem cells. Rev Bras Hematol Hemoter. 2013; 35: 62–7.
Garate A, Murua A, Orive G, Hernández RM, Pedraz JL. Stem cells in alginate bioscaffolds. Ther Deliv. 2012; 3(6): 761–74.
Liu J, Zhou H, Weir MD, Xu HHK, Chen Q, Trotman CA. Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering. Tissue Eng Part A. 2012; 18(21–22): 2303–14.
Kumbhar SG, Pawar SH. Synthesis and characterization of chitosan-alginate scaffolds for seeding human umbilical cord derived mesenchymal stem cells. Biomed Mater Eng. 2016; 27(6): 561–75.
Soleimani M, Khorsandi L, Atashi A, Nejaddehbashi F. Chondrogenic differentiation of human umbilical cord blood-derived unrestricted somatic stem cells on a 3D beta-tricalcium Phosphate-alginate-gelatin scaffold. Cell J. 2014; 16: 43–52.
Azizian S, Khatami F, Modaresifar K, Mosaffa N, Peirovi H, Tayebi L, Bahrami S, Redl H, Niknejad H. Immunological compatibility status of placenta-derived stem cells is mediated by scaffold 3D structure. Artif Cells, Nanomedicine, Biotechnol. 2018; 46(sup1): 876–84.
Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012; 37: 106–26.
Utomo DN, Mahyudin F, Wardhana TH, Purwati P, Brahmana F, Gusti AWR. Physicobiochemical characteristics and chondrogenic differentiation of bone marrow mesenchymal stem cells (hBM-MSCs) in biodegradable porous sponge bovine cartilage scaffold. Int J Biomater. 2019; 2019: 1–11.
Chen S, Zhang Q, Nakamoto T, Kawazoe N, Chen G. Gelatin scaffolds with controlled pore structure and mechanical property for cartilage tissue engineering. Tissue Eng Part C Methods. 2016; 22(3): 189–98.
Bekri A, Drapeau P. Glycine promotes the survival of a subpopulation of neural stem cells. Front cell Dev Biol. 2018; 6: 1–11.
Higuera GA, Schop D, Spitters TWGM, van Dijkhuizen-Radersma R, Bracke M, de Bruijn JD, Martens D, Karperien M, van Boxtel A, van Blitterswijk CA. Patterns of amino acid metabolism by proliferating human mesenchymal stem cells. Tissue Eng Part A. 2012; 18(5–6): 654–64.
Huh JE, Choi JY, Shin YO, Park DS, Kang J, Nam D, Choi DY, Lee JD. Arginine enhances osteoblastogenesis and inhibits adipogenesis through the regulation of Wnt and NFATc signaling in human mesenchymal stem cells. Int J Mol Sci. 2014; 15(7): 13010–29.
Liu J, Tao H, Wang H, Dong F, Zhang R, Li J, Ge P, Song P, Zhang H, Xu P, Liu X, Shen C. Biological behavior of human nucleus pulposus mesenchymal stem cells in response to changes in the acidic environment during intervertebral disc degeneration. Stem Cells Dev. 2017; 26(12): 901–11.
- Every manuscript submitted to must observe the policy and terms set by the Dental Journal (Majalah Kedokteran Gigi).
- Publication rights to manuscript content published by the Dental Journal (Majalah Kedokteran Gigi) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
- The Dental Journal (Majalah Kedokteran Gigi) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
